nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—Diethylpropion—obesity	0.259	1	CrCtD
Levomilnacipran—Serotonin Uptake Inhibitors—Sibutramine—obesity	0.126	0.372	CiPCiCtD
Levomilnacipran—Milnacipran—Diethylpropion—obesity	0.117	0.815	CrCrCtD
Levomilnacipran—Norepinephrine Uptake Inhibitors—Bupropion—obesity	0.112	0.332	CiPCiCtD
Levomilnacipran—Norepinephrine Uptake Inhibitors—Sibutramine—obesity	0.1	0.296	CiPCiCtD
Levomilnacipran—SLC6A4—obesity	0.0501	1	CbGaD
Levomilnacipran—Diethylpropion—Methamphetamine—obesity	0.0266	0.185	CrCrCtD
Levomilnacipran—SLC6A2—Diethylpropion—obesity	0.0169	0.109	CbGbCtD
Levomilnacipran—SLC6A4—Sibutramine—obesity	0.0153	0.099	CbGbCtD
Levomilnacipran—SLC6A2—Sibutramine—obesity	0.0128	0.0828	CbGbCtD
Levomilnacipran—SLC6A2—Phendimetrazine—obesity	0.0128	0.0828	CbGbCtD
Levomilnacipran—SLC6A4—Phentermine—obesity	0.0116	0.0751	CbGbCtD
Levomilnacipran—SLC6A2—Benzphetamine—obesity	0.00968	0.0628	CbGbCtD
Levomilnacipran—SLC6A2—Phentermine—obesity	0.00968	0.0628	CbGbCtD
Levomilnacipran—SLC6A4—Methamphetamine—obesity	0.00925	0.06	CbGbCtD
Levomilnacipran—SLC6A2—Phenylpropanolamine—obesity	0.00923	0.0599	CbGbCtD
Levomilnacipran—SLC6A2—Bupropion—obesity	0.00823	0.0534	CbGbCtD
Levomilnacipran—SLC6A2—Methamphetamine—obesity	0.00774	0.0502	CbGbCtD
Levomilnacipran—CYP2C8—Bupropion—obesity	0.00387	0.0251	CbGbCtD
Levomilnacipran—CYP2D6—Phentermine—obesity	0.0029	0.0188	CbGbCtD
Levomilnacipran—CYP2C8—Cimetidine—obesity	0.00284	0.0184	CbGbCtD
Levomilnacipran—CYP2D6—Bupropion—obesity	0.00247	0.016	CbGbCtD
Levomilnacipran—CYP3A4—Sibutramine—obesity	0.00243	0.0158	CbGbCtD
Levomilnacipran—CYP2C19—Cimetidine—obesity	0.00238	0.0155	CbGbCtD
Levomilnacipran—CYP2D6—Methamphetamine—obesity	0.00232	0.015	CbGbCtD
Levomilnacipran—ABCB1—Cimetidine—obesity	0.00192	0.0125	CbGbCtD
Levomilnacipran—CYP3A4—Benzphetamine—obesity	0.00185	0.012	CbGbCtD
Levomilnacipran—CYP2D6—Cimetidine—obesity	0.00181	0.0117	CbGbCtD
Levomilnacipran—CYP3A4—Bupropion—obesity	0.00157	0.0102	CbGbCtD
Levomilnacipran—CYP2C19—Topiramate—obesity	0.00156	0.0101	CbGbCtD
Levomilnacipran—CYP3A4—Orlistat—obesity	0.00128	0.0083	CbGbCtD
Levomilnacipran—CYP3A4—Cimetidine—obesity	0.00115	0.00747	CbGbCtD
Levomilnacipran—SLC6A2—sympathetic nervous system—obesity	0.000792	0.194	CbGeAlD
Levomilnacipran—CYP3A4—Topiramate—obesity	0.000754	0.00489	CbGbCtD
Levomilnacipran—SLC6A2—autonomic nervous system—obesity	0.000532	0.131	CbGeAlD
Levomilnacipran—Milnacipran—SLC6A4—obesity	0.00028	0.717	CrCbGaD
Levomilnacipran—SLC6A4—hindbrain—obesity	0.000255	0.0626	CbGeAlD
Levomilnacipran—CYP2J2—cardiovascular system—obesity	0.000221	0.0543	CbGeAlD
Levomilnacipran—CYP2J2—pituitary gland—obesity	0.000196	0.048	CbGeAlD
Levomilnacipran—SLC6A4—respiratory system—obesity	0.000156	0.0382	CbGeAlD
Levomilnacipran—CYP2J2—endocrine gland—obesity	0.000152	0.0372	CbGeAlD
Levomilnacipran—SLC6A2—respiratory system—obesity	0.000137	0.0336	CbGeAlD
Levomilnacipran—CYP2J2—liver—obesity	0.000137	0.0336	CbGeAlD
Levomilnacipran—CYP2D6—hindbrain—obesity	0.000123	0.0302	CbGeAlD
Levomilnacipran—SLC6A4—digestive system—obesity	9.89e-05	0.0243	CbGeAlD
Levomilnacipran—SLC6A2—adrenal gland—obesity	8.29e-05	0.0204	CbGeAlD
Levomilnacipran—CYP2C19—digestive system—obesity	8.19e-05	0.0201	CbGeAlD
Levomilnacipran—SLC6A4—endocrine gland—obesity	8.17e-05	0.0201	CbGeAlD
Levomilnacipran—CYP2C8—pituitary gland—obesity	7.63e-05	0.0187	CbGeAlD
Levomilnacipran—Pethidine—SLC6A4—obesity	7.25e-05	0.186	CrCbGaD
Levomilnacipran—SLC6A2—endocrine gland—obesity	7.19e-05	0.0177	CbGeAlD
Levomilnacipran—CYP2C19—endocrine gland—obesity	6.77e-05	0.0166	CbGeAlD
Levomilnacipran—CYP2C19—liver—obesity	6.1e-05	0.015	CbGeAlD
Levomilnacipran—CYP2C8—endocrine gland—obesity	5.91e-05	0.0145	CbGeAlD
Levomilnacipran—ABCB1—islet of Langerhans—obesity	5.71e-05	0.014	CbGeAlD
Levomilnacipran—ABCB1—respiratory system—obesity	5.39e-05	0.0132	CbGeAlD
Levomilnacipran—CYP2C8—liver—obesity	5.33e-05	0.0131	CbGeAlD
Levomilnacipran—Asthenia—Cimetidine—obesity	4.94e-05	0.00142	CcSEcCtD
Levomilnacipran—Urinary tract infection—Bupropion—obesity	4.89e-05	0.0014	CcSEcCtD
Levomilnacipran—CYP3A4—digestive system—obesity	4.84e-05	0.0119	CbGeAlD
Levomilnacipran—Eye disorder—Sibutramine—obesity	4.84e-05	0.00139	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Orlistat—obesity	4.82e-05	0.00139	CcSEcCtD
Levomilnacipran—Dizziness—Diethylpropion—obesity	4.79e-05	0.00138	CcSEcCtD
Levomilnacipran—CYP2D6—digestive system—obesity	4.77e-05	0.0117	CbGeAlD
Levomilnacipran—Diarrhoea—Cimetidine—obesity	4.71e-05	0.00135	CcSEcCtD
Levomilnacipran—Angiopathy—Sibutramine—obesity	4.7e-05	0.00135	CcSEcCtD
Levomilnacipran—Mental disorder—Orlistat—obesity	4.69e-05	0.00135	CcSEcCtD
Levomilnacipran—Malnutrition—Orlistat—obesity	4.66e-05	0.00134	CcSEcCtD
Levomilnacipran—Chills—Sibutramine—obesity	4.65e-05	0.00134	CcSEcCtD
Levomilnacipran—Vomiting—Diethylpropion—obesity	4.6e-05	0.00132	CcSEcCtD
Levomilnacipran—Flatulence—Orlistat—obesity	4.59e-05	0.00132	CcSEcCtD
Levomilnacipran—Rash—Diethylpropion—obesity	4.56e-05	0.00131	CcSEcCtD
Levomilnacipran—Dysgeusia—Orlistat—obesity	4.56e-05	0.00131	CcSEcCtD
Levomilnacipran—Dermatitis—Diethylpropion—obesity	4.56e-05	0.00131	CcSEcCtD
Levomilnacipran—Dizziness—Cimetidine—obesity	4.55e-05	0.00131	CcSEcCtD
Levomilnacipran—Headache—Diethylpropion—obesity	4.53e-05	0.0013	CcSEcCtD
Levomilnacipran—ABCB1—adrenal cortex—obesity	4.53e-05	0.0111	CbGeAlD
Levomilnacipran—Hepatitis—Bupropion—obesity	4.52e-05	0.0013	CcSEcCtD
Levomilnacipran—Malnutrition—Sibutramine—obesity	4.51e-05	0.0013	CcSEcCtD
Levomilnacipran—Hallucination—Bupropion—obesity	4.49e-05	0.00129	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Bupropion—obesity	4.49e-05	0.00129	CcSEcCtD
Levomilnacipran—Libido decreased—Topiramate—obesity	4.48e-05	0.00129	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Bupropion—obesity	4.46e-05	0.00128	CcSEcCtD
Levomilnacipran—Oedema peripheral—Bupropion—obesity	4.45e-05	0.00128	CcSEcCtD
Levomilnacipran—Hot flush—Topiramate—obesity	4.45e-05	0.00128	CcSEcCtD
Levomilnacipran—Flatulence—Sibutramine—obesity	4.44e-05	0.00128	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Bupropion—obesity	4.44e-05	0.00127	CcSEcCtD
Levomilnacipran—Urethral disorder—Bupropion—obesity	4.43e-05	0.00127	CcSEcCtD
Levomilnacipran—Tension—Sibutramine—obesity	4.42e-05	0.00127	CcSEcCtD
Levomilnacipran—Dysgeusia—Sibutramine—obesity	4.42e-05	0.00127	CcSEcCtD
Levomilnacipran—Menopausal symptoms—Topiramate—obesity	4.41e-05	0.00127	CcSEcCtD
Levomilnacipran—Vision blurred—Orlistat—obesity	4.39e-05	0.00126	CcSEcCtD
Levomilnacipran—Vomiting—Cimetidine—obesity	4.38e-05	0.00126	CcSEcCtD
Levomilnacipran—Thirst—Topiramate—obesity	4.37e-05	0.00126	CcSEcCtD
Levomilnacipran—Rash—Cimetidine—obesity	4.34e-05	0.00125	CcSEcCtD
Levomilnacipran—Dermatitis—Cimetidine—obesity	4.34e-05	0.00125	CcSEcCtD
Levomilnacipran—Headache—Cimetidine—obesity	4.31e-05	0.00124	CcSEcCtD
Levomilnacipran—Nausea—Diethylpropion—obesity	4.3e-05	0.00124	CcSEcCtD
Levomilnacipran—Erythema multiforme—Bupropion—obesity	4.27e-05	0.00123	CcSEcCtD
Levomilnacipran—Vision blurred—Sibutramine—obesity	4.25e-05	0.00122	CcSEcCtD
Levomilnacipran—Tremor—Sibutramine—obesity	4.22e-05	0.00121	CcSEcCtD
Levomilnacipran—Eye disorder—Bupropion—obesity	4.22e-05	0.00121	CcSEcCtD
Levomilnacipran—Cardiac disorder—Bupropion—obesity	4.19e-05	0.0012	CcSEcCtD
Levomilnacipran—Flushing—Bupropion—obesity	4.19e-05	0.0012	CcSEcCtD
Levomilnacipran—Hyponatraemia—Topiramate—obesity	4.18e-05	0.0012	CcSEcCtD
Levomilnacipran—Agitation—Sibutramine—obesity	4.14e-05	0.00119	CcSEcCtD
Levomilnacipran—ABCB1—cardiovascular system—obesity	4.13e-05	0.0101	CbGeAlD
Levomilnacipran—Disturbance in sexual arousal—Topiramate—obesity	4.13e-05	0.00119	CcSEcCtD
Levomilnacipran—Palpitations—Orlistat—obesity	4.12e-05	0.00118	CcSEcCtD
Levomilnacipran—Angiopathy—Bupropion—obesity	4.1e-05	0.00118	CcSEcCtD
Levomilnacipran—Migraine—Topiramate—obesity	4.09e-05	0.00118	CcSEcCtD
Levomilnacipran—Nausea—Cimetidine—obesity	4.09e-05	0.00118	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Bupropion—obesity	4.07e-05	0.00117	CcSEcCtD
Levomilnacipran—Chills—Bupropion—obesity	4.05e-05	0.00116	CcSEcCtD
Levomilnacipran—Syncope—Sibutramine—obesity	4.04e-05	0.00116	CcSEcCtD
Levomilnacipran—Convulsion—Orlistat—obesity	4.04e-05	0.00116	CcSEcCtD
Levomilnacipran—Leukopenia—Sibutramine—obesity	4.04e-05	0.00116	CcSEcCtD
Levomilnacipran—CYP3A4—endocrine gland—obesity	4e-05	0.00983	CbGeAlD
Levomilnacipran—Palpitations—Sibutramine—obesity	3.98e-05	0.00114	CcSEcCtD
Levomilnacipran—Irritability—Topiramate—obesity	3.97e-05	0.00114	CcSEcCtD
Levomilnacipran—Chest pain—Orlistat—obesity	3.97e-05	0.00114	CcSEcCtD
Levomilnacipran—Loss of consciousness—Sibutramine—obesity	3.96e-05	0.00114	CcSEcCtD
Levomilnacipran—Mental disorder—Bupropion—obesity	3.96e-05	0.00114	CcSEcCtD
Levomilnacipran—Urinary retention—Topiramate—obesity	3.95e-05	0.00114	CcSEcCtD
Levomilnacipran—Anxiety—Orlistat—obesity	3.95e-05	0.00114	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	3.94e-05	0.00113	CcSEcCtD
Levomilnacipran—CYP2D6—endocrine gland—obesity	3.94e-05	0.00967	CbGeAlD
Levomilnacipran—Malnutrition—Bupropion—obesity	3.93e-05	0.00113	CcSEcCtD
Levomilnacipran—Convulsion—Sibutramine—obesity	3.91e-05	0.00112	CcSEcCtD
Levomilnacipran—Hypertension—Sibutramine—obesity	3.89e-05	0.00112	CcSEcCtD
Levomilnacipran—Dry mouth—Orlistat—obesity	3.88e-05	0.00111	CcSEcCtD
Levomilnacipran—Flatulence—Bupropion—obesity	3.87e-05	0.00111	CcSEcCtD
Levomilnacipran—Tension—Bupropion—obesity	3.86e-05	0.00111	CcSEcCtD
Levomilnacipran—Dysgeusia—Bupropion—obesity	3.85e-05	0.00111	CcSEcCtD
Levomilnacipran—Liver function test abnormal—Topiramate—obesity	3.84e-05	0.0011	CcSEcCtD
Levomilnacipran—Chest pain—Sibutramine—obesity	3.84e-05	0.0011	CcSEcCtD
Levomilnacipran—Anxiety—Sibutramine—obesity	3.83e-05	0.0011	CcSEcCtD
Levomilnacipran—Pethidine—ALB—obesity	3.81e-05	0.0976	CrCbGaD
Levomilnacipran—Infection—Orlistat—obesity	3.78e-05	0.00109	CcSEcCtD
Levomilnacipran—Breast disorder—Topiramate—obesity	3.76e-05	0.00108	CcSEcCtD
Levomilnacipran—Dry mouth—Sibutramine—obesity	3.75e-05	0.00108	CcSEcCtD
Levomilnacipran—Nervous system disorder—Orlistat—obesity	3.73e-05	0.00107	CcSEcCtD
Levomilnacipran—Vision blurred—Bupropion—obesity	3.7e-05	0.00106	CcSEcCtD
Levomilnacipran—Skin disorder—Orlistat—obesity	3.69e-05	0.00106	CcSEcCtD
Levomilnacipran—Tremor—Bupropion—obesity	3.68e-05	0.00106	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Orlistat—obesity	3.68e-05	0.00106	CcSEcCtD
Levomilnacipran—ABCB1—pituitary gland—obesity	3.66e-05	0.00898	CbGeAlD
Levomilnacipran—Infection—Sibutramine—obesity	3.66e-05	0.00105	CcSEcCtD
Levomilnacipran—ABCB1—adipose tissue—obesity	3.64e-05	0.00895	CbGeAlD
Levomilnacipran—Shock—Sibutramine—obesity	3.62e-05	0.00104	CcSEcCtD
Levomilnacipran—Abdominal distension—Topiramate—obesity	3.62e-05	0.00104	CcSEcCtD
Levomilnacipran—Agitation—Bupropion—obesity	3.61e-05	0.00104	CcSEcCtD
Levomilnacipran—CYP3A4—liver—obesity	3.61e-05	0.00886	CbGeAlD
Levomilnacipran—Thrombocytopenia—Sibutramine—obesity	3.6e-05	0.00104	CcSEcCtD
Levomilnacipran—Tachycardia—Sibutramine—obesity	3.59e-05	0.00103	CcSEcCtD
Levomilnacipran—Skin disorder—Sibutramine—obesity	3.57e-05	0.00103	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Sibutramine—obesity	3.56e-05	0.00102	CcSEcCtD
Levomilnacipran—CYP2D6—liver—obesity	3.55e-05	0.00872	CbGeAlD
Levomilnacipran—Syncope—Bupropion—obesity	3.53e-05	0.00101	CcSEcCtD
Levomilnacipran—Leukopenia—Bupropion—obesity	3.52e-05	0.00101	CcSEcCtD
Levomilnacipran—Anorexia—Sibutramine—obesity	3.51e-05	0.00101	CcSEcCtD
Levomilnacipran—Angina pectoris—Topiramate—obesity	3.5e-05	0.00101	CcSEcCtD
Levomilnacipran—Palpitations—Bupropion—obesity	3.47e-05	0.000998	CcSEcCtD
Levomilnacipran—Loss of consciousness—Bupropion—obesity	3.46e-05	0.000992	CcSEcCtD
Levomilnacipran—Insomnia—Orlistat—obesity	3.44e-05	0.000988	CcSEcCtD
Levomilnacipran—Hypotension—Sibutramine—obesity	3.44e-05	0.000988	CcSEcCtD
Levomilnacipran—ABCB1—digestive system—obesity	3.43e-05	0.00842	CbGeAlD
Levomilnacipran—Paraesthesia—Orlistat—obesity	3.41e-05	0.000981	CcSEcCtD
Levomilnacipran—Convulsion—Bupropion—obesity	3.41e-05	0.000978	CcSEcCtD
Levomilnacipran—Hypertension—Bupropion—obesity	3.39e-05	0.000975	CcSEcCtD
Levomilnacipran—Neutropenia—Topiramate—obesity	3.36e-05	0.000965	CcSEcCtD
Levomilnacipran—Dysuria—Topiramate—obesity	3.36e-05	0.000965	CcSEcCtD
Levomilnacipran—Dyspepsia—Orlistat—obesity	3.35e-05	0.000962	CcSEcCtD
Levomilnacipran—Chest pain—Bupropion—obesity	3.35e-05	0.000961	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Topiramate—obesity	3.34e-05	0.00096	CcSEcCtD
Levomilnacipran—Anxiety—Bupropion—obesity	3.34e-05	0.000958	CcSEcCtD
Levomilnacipran—Insomnia—Sibutramine—obesity	3.33e-05	0.000956	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	3.32e-05	0.000955	CcSEcCtD
Levomilnacipran—Pollakiuria—Topiramate—obesity	3.32e-05	0.000954	CcSEcCtD
Levomilnacipran—Erectile dysfunction—Topiramate—obesity	3.31e-05	0.000951	CcSEcCtD
Levomilnacipran—Decreased appetite—Orlistat—obesity	3.31e-05	0.00095	CcSEcCtD
Levomilnacipran—Paraesthesia—Sibutramine—obesity	3.3e-05	0.000949	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Orlistat—obesity	3.28e-05	0.000943	CcSEcCtD
Levomilnacipran—Dyspnoea—Sibutramine—obesity	3.28e-05	0.000942	CcSEcCtD
Levomilnacipran—Fatigue—Orlistat—obesity	3.28e-05	0.000942	CcSEcCtD
Levomilnacipran—Dry mouth—Bupropion—obesity	3.27e-05	0.00094	CcSEcCtD
Levomilnacipran—Somnolence—Sibutramine—obesity	3.27e-05	0.00094	CcSEcCtD
Levomilnacipran—ABCB1—adrenal gland—obesity	3.27e-05	0.00803	CbGeAlD
Levomilnacipran—Weight decreased—Topiramate—obesity	3.25e-05	0.000934	CcSEcCtD
Levomilnacipran—Dyspepsia—Sibutramine—obesity	3.24e-05	0.000931	CcSEcCtD
Levomilnacipran—Decreased appetite—Sibutramine—obesity	3.2e-05	0.000919	CcSEcCtD
Levomilnacipran—Infection—Bupropion—obesity	3.19e-05	0.000916	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Topiramate—obesity	3.18e-05	0.000913	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Sibutramine—obesity	3.18e-05	0.000913	CcSEcCtD
Levomilnacipran—Shock—Bupropion—obesity	3.16e-05	0.000907	CcSEcCtD
Levomilnacipran—Constipation—Sibutramine—obesity	3.15e-05	0.000904	CcSEcCtD
Levomilnacipran—Nervous system disorder—Bupropion—obesity	3.15e-05	0.000904	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Bupropion—obesity	3.14e-05	0.000902	CcSEcCtD
Levomilnacipran—Tachycardia—Bupropion—obesity	3.13e-05	0.000899	CcSEcCtD
Levomilnacipran—Skin disorder—Bupropion—obesity	3.12e-05	0.000895	CcSEcCtD
Levomilnacipran—Urinary tract infection—Topiramate—obesity	3.12e-05	0.000895	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Orlistat—obesity	3.11e-05	0.000893	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Bupropion—obesity	3.1e-05	0.000891	CcSEcCtD
Levomilnacipran—Anorexia—Bupropion—obesity	3.06e-05	0.000878	CcSEcCtD
Levomilnacipran—Haematuria—Topiramate—obesity	3.06e-05	0.000878	CcSEcCtD
Levomilnacipran—Urticaria—Orlistat—obesity	3.02e-05	0.000868	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Sibutramine—obesity	3.01e-05	0.000864	CcSEcCtD
Levomilnacipran—Abdominal pain—Orlistat—obesity	3.01e-05	0.000863	CcSEcCtD
Levomilnacipran—Body temperature increased—Orlistat—obesity	3.01e-05	0.000863	CcSEcCtD
Levomilnacipran—Hypotension—Bupropion—obesity	3e-05	0.000861	CcSEcCtD
Levomilnacipran—Urticaria—Sibutramine—obesity	2.92e-05	0.00084	CcSEcCtD
Levomilnacipran—Body temperature increased—Sibutramine—obesity	2.91e-05	0.000836	CcSEcCtD
Levomilnacipran—Abdominal pain—Sibutramine—obesity	2.91e-05	0.000836	CcSEcCtD
Levomilnacipran—Insomnia—Bupropion—obesity	2.9e-05	0.000834	CcSEcCtD
Levomilnacipran—Paraesthesia—Bupropion—obesity	2.88e-05	0.000828	CcSEcCtD
Levomilnacipran—Hepatitis—Topiramate—obesity	2.88e-05	0.000826	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Topiramate—obesity	2.86e-05	0.000822	CcSEcCtD
Levomilnacipran—Hallucination—Topiramate—obesity	2.86e-05	0.000822	CcSEcCtD
Levomilnacipran—Dyspnoea—Bupropion—obesity	2.86e-05	0.000822	CcSEcCtD
Levomilnacipran—Somnolence—Bupropion—obesity	2.85e-05	0.000819	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Topiramate—obesity	2.84e-05	0.000816	CcSEcCtD
Levomilnacipran—Oedema peripheral—Topiramate—obesity	2.83e-05	0.000814	CcSEcCtD
Levomilnacipran—ABCB1—endocrine gland—obesity	2.83e-05	0.00696	CbGeAlD
Levomilnacipran—Connective tissue disorder—Topiramate—obesity	2.83e-05	0.000812	CcSEcCtD
Levomilnacipran—Dyspepsia—Bupropion—obesity	2.82e-05	0.000811	CcSEcCtD
Levomilnacipran—Urethral disorder—Topiramate—obesity	2.82e-05	0.00081	CcSEcCtD
Levomilnacipran—Hypersensitivity—Orlistat—obesity	2.8e-05	0.000805	CcSEcCtD
Levomilnacipran—Decreased appetite—Bupropion—obesity	2.79e-05	0.000801	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Bupropion—obesity	2.77e-05	0.000796	CcSEcCtD
Levomilnacipran—Fatigue—Bupropion—obesity	2.77e-05	0.000795	CcSEcCtD
Levomilnacipran—Constipation—Bupropion—obesity	2.74e-05	0.000788	CcSEcCtD
Levomilnacipran—Asthenia—Orlistat—obesity	2.73e-05	0.000784	CcSEcCtD
Levomilnacipran—Erythema multiforme—Topiramate—obesity	2.72e-05	0.000781	CcSEcCtD
Levomilnacipran—Hypersensitivity—Sibutramine—obesity	2.71e-05	0.000779	CcSEcCtD
Levomilnacipran—Pruritus—Orlistat—obesity	2.69e-05	0.000773	CcSEcCtD
Levomilnacipran—Eye disorder—Topiramate—obesity	2.69e-05	0.000772	CcSEcCtD
Levomilnacipran—Cardiac disorder—Topiramate—obesity	2.67e-05	0.000767	CcSEcCtD
Levomilnacipran—Flushing—Topiramate—obesity	2.67e-05	0.000767	CcSEcCtD
Levomilnacipran—Asthenia—Sibutramine—obesity	2.64e-05	0.000758	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Bupropion—obesity	2.62e-05	0.000754	CcSEcCtD
Levomilnacipran—Angiopathy—Topiramate—obesity	2.61e-05	0.00075	CcSEcCtD
Levomilnacipran—Pruritus—Sibutramine—obesity	2.6e-05	0.000748	CcSEcCtD
Levomilnacipran—Diarrhoea—Orlistat—obesity	2.6e-05	0.000747	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Topiramate—obesity	2.59e-05	0.000745	CcSEcCtD
Levomilnacipran—Chills—Topiramate—obesity	2.58e-05	0.000742	CcSEcCtD
Levomilnacipran—ABCB1—liver—obesity	2.55e-05	0.00627	CbGeAlD
Levomilnacipran—Urticaria—Bupropion—obesity	2.55e-05	0.000732	CcSEcCtD
Levomilnacipran—Abdominal pain—Bupropion—obesity	2.54e-05	0.000729	CcSEcCtD
Levomilnacipran—Body temperature increased—Bupropion—obesity	2.54e-05	0.000729	CcSEcCtD
Levomilnacipran—Mental disorder—Topiramate—obesity	2.52e-05	0.000724	CcSEcCtD
Levomilnacipran—Diarrhoea—Sibutramine—obesity	2.52e-05	0.000723	CcSEcCtD
Levomilnacipran—Dizziness—Orlistat—obesity	2.51e-05	0.000722	CcSEcCtD
Levomilnacipran—Malnutrition—Topiramate—obesity	2.5e-05	0.000719	CcSEcCtD
Levomilnacipran—Flatulence—Topiramate—obesity	2.47e-05	0.000709	CcSEcCtD
Levomilnacipran—Tension—Topiramate—obesity	2.46e-05	0.000706	CcSEcCtD
Levomilnacipran—Dysgeusia—Topiramate—obesity	2.45e-05	0.000705	CcSEcCtD
Levomilnacipran—Dizziness—Sibutramine—obesity	2.43e-05	0.000699	CcSEcCtD
Levomilnacipran—Vomiting—Orlistat—obesity	2.42e-05	0.000695	CcSEcCtD
Levomilnacipran—Rash—Orlistat—obesity	2.4e-05	0.000689	CcSEcCtD
Levomilnacipran—Dermatitis—Orlistat—obesity	2.4e-05	0.000688	CcSEcCtD
Levomilnacipran—Headache—Orlistat—obesity	2.38e-05	0.000684	CcSEcCtD
Levomilnacipran—Hypersensitivity—Bupropion—obesity	2.36e-05	0.000679	CcSEcCtD
Levomilnacipran—Vision blurred—Topiramate—obesity	2.36e-05	0.000678	CcSEcCtD
Levomilnacipran—Tremor—Topiramate—obesity	2.35e-05	0.000674	CcSEcCtD
Levomilnacipran—Vomiting—Sibutramine—obesity	2.34e-05	0.000672	CcSEcCtD
Levomilnacipran—Rash—Sibutramine—obesity	2.32e-05	0.000667	CcSEcCtD
Levomilnacipran—Dermatitis—Sibutramine—obesity	2.32e-05	0.000666	CcSEcCtD
Levomilnacipran—Headache—Sibutramine—obesity	2.31e-05	0.000662	CcSEcCtD
Levomilnacipran—Asthenia—Bupropion—obesity	2.3e-05	0.000661	CcSEcCtD
Levomilnacipran—Agitation—Topiramate—obesity	2.3e-05	0.000661	CcSEcCtD
Levomilnacipran—Pruritus—Bupropion—obesity	2.27e-05	0.000652	CcSEcCtD
Levomilnacipran—Nausea—Orlistat—obesity	2.26e-05	0.000649	CcSEcCtD
Levomilnacipran—Syncope—Topiramate—obesity	2.25e-05	0.000645	CcSEcCtD
Levomilnacipran—Leukopenia—Topiramate—obesity	2.24e-05	0.000644	CcSEcCtD
Levomilnacipran—Palpitations—Topiramate—obesity	2.21e-05	0.000636	CcSEcCtD
Levomilnacipran—Loss of consciousness—Topiramate—obesity	2.2e-05	0.000632	CcSEcCtD
Levomilnacipran—Diarrhoea—Bupropion—obesity	2.2e-05	0.000631	CcSEcCtD
Levomilnacipran—Nausea—Sibutramine—obesity	2.19e-05	0.000628	CcSEcCtD
Levomilnacipran—Convulsion—Topiramate—obesity	2.17e-05	0.000623	CcSEcCtD
Levomilnacipran—Hypertension—Topiramate—obesity	2.16e-05	0.000621	CcSEcCtD
Levomilnacipran—Chest pain—Topiramate—obesity	2.13e-05	0.000612	CcSEcCtD
Levomilnacipran—Anxiety—Topiramate—obesity	2.12e-05	0.00061	CcSEcCtD
Levomilnacipran—Dizziness—Bupropion—obesity	2.12e-05	0.000609	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	2.12e-05	0.000608	CcSEcCtD
Levomilnacipran—Dry mouth—Topiramate—obesity	2.09e-05	0.000599	CcSEcCtD
Levomilnacipran—Vomiting—Bupropion—obesity	2.04e-05	0.000586	CcSEcCtD
Levomilnacipran—Infection—Topiramate—obesity	2.03e-05	0.000583	CcSEcCtD
Levomilnacipran—Rash—Bupropion—obesity	2.02e-05	0.000581	CcSEcCtD
Levomilnacipran—Dermatitis—Bupropion—obesity	2.02e-05	0.000581	CcSEcCtD
Levomilnacipran—Shock—Topiramate—obesity	2.01e-05	0.000578	CcSEcCtD
Levomilnacipran—Headache—Bupropion—obesity	2.01e-05	0.000577	CcSEcCtD
Levomilnacipran—Nervous system disorder—Topiramate—obesity	2e-05	0.000576	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Topiramate—obesity	2e-05	0.000575	CcSEcCtD
Levomilnacipran—Tachycardia—Topiramate—obesity	1.99e-05	0.000573	CcSEcCtD
Levomilnacipran—Skin disorder—Topiramate—obesity	1.99e-05	0.00057	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Topiramate—obesity	1.98e-05	0.000568	CcSEcCtD
Levomilnacipran—Anorexia—Topiramate—obesity	1.95e-05	0.00056	CcSEcCtD
Levomilnacipran—Hypotension—Topiramate—obesity	1.91e-05	0.000549	CcSEcCtD
Levomilnacipran—Nausea—Bupropion—obesity	1.91e-05	0.000547	CcSEcCtD
Levomilnacipran—Insomnia—Topiramate—obesity	1.85e-05	0.000531	CcSEcCtD
Levomilnacipran—Paraesthesia—Topiramate—obesity	1.84e-05	0.000527	CcSEcCtD
Levomilnacipran—Dyspnoea—Topiramate—obesity	1.82e-05	0.000523	CcSEcCtD
Levomilnacipran—Somnolence—Topiramate—obesity	1.82e-05	0.000522	CcSEcCtD
Levomilnacipran—Dyspepsia—Topiramate—obesity	1.8e-05	0.000517	CcSEcCtD
Levomilnacipran—Decreased appetite—Topiramate—obesity	1.78e-05	0.00051	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Topiramate—obesity	1.76e-05	0.000507	CcSEcCtD
Levomilnacipran—Fatigue—Topiramate—obesity	1.76e-05	0.000506	CcSEcCtD
Levomilnacipran—Constipation—Topiramate—obesity	1.75e-05	0.000502	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Topiramate—obesity	1.67e-05	0.00048	CcSEcCtD
Levomilnacipran—Urticaria—Topiramate—obesity	1.62e-05	0.000466	CcSEcCtD
Levomilnacipran—Body temperature increased—Topiramate—obesity	1.62e-05	0.000464	CcSEcCtD
Levomilnacipran—Abdominal pain—Topiramate—obesity	1.62e-05	0.000464	CcSEcCtD
Levomilnacipran—Hypersensitivity—Topiramate—obesity	1.51e-05	0.000433	CcSEcCtD
Levomilnacipran—Asthenia—Topiramate—obesity	1.47e-05	0.000421	CcSEcCtD
Levomilnacipran—Pruritus—Topiramate—obesity	1.45e-05	0.000415	CcSEcCtD
Levomilnacipran—Diarrhoea—Topiramate—obesity	1.4e-05	0.000402	CcSEcCtD
Levomilnacipran—Dizziness—Topiramate—obesity	1.35e-05	0.000388	CcSEcCtD
Levomilnacipran—Vomiting—Topiramate—obesity	1.3e-05	0.000373	CcSEcCtD
Levomilnacipran—Rash—Topiramate—obesity	1.29e-05	0.00037	CcSEcCtD
Levomilnacipran—Dermatitis—Topiramate—obesity	1.29e-05	0.00037	CcSEcCtD
Levomilnacipran—Headache—Topiramate—obesity	1.28e-05	0.000368	CcSEcCtD
Levomilnacipran—Nausea—Topiramate—obesity	1.21e-05	0.000349	CcSEcCtD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—obesity	1.27e-06	7.81e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NQO1—obesity	1.27e-06	7.78e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SCARB1—obesity	1.26e-06	7.72e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALB—obesity	1.26e-06	7.71e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SREBF1—obesity	1.25e-06	7.68e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ECHS1—obesity	1.25e-06	7.63e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HSD11B1—obesity	1.25e-06	7.63e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—UCP2—obesity	1.25e-06	7.63e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—UCP3—obesity	1.25e-06	7.63e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.24e-06	7.62e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CETP—obesity	1.24e-06	7.6e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.23e-06	7.55e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SDC1—obesity	1.23e-06	7.52e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADH1B—obesity	1.23e-06	7.5e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SREBF1—obesity	1.22e-06	7.5e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GOT2—obesity	1.22e-06	7.47e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GCG—obesity	1.22e-06	7.46e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SLC2A4—obesity	1.22e-06	7.46e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKR1C3—obesity	1.21e-06	7.39e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARGC1B—obesity	1.21e-06	7.38e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GPAM—obesity	1.21e-06	7.38e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ACSL1—obesity	1.21e-06	7.38e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.2e-06	7.37e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYCS—obesity	1.2e-06	7.37e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—FASN—obesity	1.19e-06	7.31e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GOT2—obesity	1.19e-06	7.29e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—BCHE—obesity	1.19e-06	7.28e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SCARB1—obesity	1.19e-06	7.28e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GGT1—obesity	1.18e-06	7.23e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GOT1—obesity	1.18e-06	7.23e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—FADS1—obesity	1.17e-06	7.17e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HADH—obesity	1.17e-06	7.17e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PCK1—obesity	1.17e-06	7.17e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ALB—obesity	1.17e-06	7.15e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—FASN—obesity	1.17e-06	7.14e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NCOA1—obesity	1.16e-06	7.12e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—BCHE—obesity	1.16e-06	7.11e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SREBF1—obesity	1.15e-06	7.07e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP2E1—obesity	1.15e-06	7.03e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—STK11—obesity	1.15e-06	7.02e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP19A1—obesity	1.15e-06	7.02e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ACP5—obesity	1.14e-06	6.97e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NQO1—obesity	1.13e-06	6.95e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GOT2—obesity	1.12e-06	6.87e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2E1—obesity	1.12e-06	6.86e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.11e-06	6.8e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—G6PD—obesity	1.11e-06	6.8e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NQO1—obesity	1.11e-06	6.78e-05	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—AKT1—obesity	1.11e-06	6.77e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.1e-06	6.74e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—FASN—obesity	1.1e-06	6.73e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SREBF2—obesity	1.1e-06	6.71e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HK1—obesity	1.1e-06	6.71e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—BCHE—obesity	1.09e-06	6.7e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GCG—obesity	1.09e-06	6.66e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC2A4—obesity	1.09e-06	6.66e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYCS—obesity	1.07e-06	6.57e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—COMT—obesity	1.07e-06	6.52e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GCG—obesity	1.06e-06	6.5e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC2A4—obesity	1.06e-06	6.5e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LPA—obesity	1.06e-06	6.48e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP2E1—obesity	1.06e-06	6.46e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GOT1—obesity	1.05e-06	6.45e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GGT1—obesity	1.05e-06	6.45e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARGC1A—obesity	1.05e-06	6.43e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GNB3—obesity	1.05e-06	6.43e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYCS—obesity	1.05e-06	6.42e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HMOX1—obesity	1.05e-06	6.4e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NQO1—obesity	1.04e-06	6.39e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NCOA1—obesity	1.04e-06	6.35e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LPIN1—obesity	1.04e-06	6.34e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GOT1—obesity	1.03e-06	6.3e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GGT1—obesity	1.03e-06	6.3e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—STK11—obesity	1.02e-06	6.26e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP19A1—obesity	1.02e-06	6.26e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GNAS—obesity	1.02e-06	6.26e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOA5—obesity	1.02e-06	6.22e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NCOA1—obesity	1.01e-06	6.2e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOB—obesity	1e-06	6.13e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC2A4—obesity	1e-06	6.13e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GCG—obesity	1e-06	6.13e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—STK11—obesity	9.98e-07	6.11e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP19A1—obesity	9.98e-07	6.11e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYCS—obesity	9.88e-07	6.05e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GOT1—obesity	9.69e-07	5.93e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GGT1—obesity	9.69e-07	5.93e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CLOCK—obesity	9.68e-07	5.93e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC22A1—obesity	9.68e-07	5.93e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LPL—obesity	9.56e-07	5.86e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NCOA1—obesity	9.55e-07	5.84e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—COMT—obesity	9.51e-07	5.82e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SULT2A1—obesity	9.44e-07	5.78e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GLP1R—obesity	9.44e-07	5.78e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—STK11—obesity	9.41e-07	5.76e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP19A1—obesity	9.41e-07	5.76e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GNB3—obesity	9.38e-07	5.74e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARGC1A—obesity	9.38e-07	5.74e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HMOX1—obesity	9.33e-07	5.71e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GPX1—obesity	9.33e-07	5.71e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—DPYD—obesity	9.28e-07	5.69e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—COMT—obesity	9.28e-07	5.68e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARGC1A—obesity	9.15e-07	5.6e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GNB3—obesity	9.15e-07	5.6e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GNAS—obesity	9.13e-07	5.59e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HMOX1—obesity	9.11e-07	5.58e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CD36—obesity	9.09e-07	5.56e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOB—obesity	8.94e-07	5.47e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PRKAR2B—obesity	8.94e-07	5.47e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GNAS—obesity	8.91e-07	5.46e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—DCN—obesity	8.87e-07	5.43e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—COMT—obesity	8.75e-07	5.36e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOB—obesity	8.73e-07	5.34e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CPT1A—obesity	8.63e-07	5.29e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GNB3—obesity	8.62e-07	5.28e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARGC1A—obesity	8.62e-07	5.28e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—MTHFR—obesity	8.61e-07	5.27e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HMOX1—obesity	8.58e-07	5.26e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LPL—obesity	8.54e-07	5.23e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NAMPT—obesity	8.47e-07	5.18e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARA—obesity	8.45e-07	5.17e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LIPC—obesity	8.41e-07	5.15e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GCK—obesity	8.41e-07	5.15e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GNAS—obesity	8.4e-07	5.14e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOC3—obesity	8.36e-07	5.12e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LPL—obesity	8.33e-07	5.1e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GPX1—obesity	8.33e-07	5.1e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOB—obesity	8.22e-07	5.03e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AGT—obesity	8.18e-07	5.01e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GPX1—obesity	8.13e-07	4.98e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CETP—obesity	8.12e-07	4.97e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CD36—obesity	8.11e-07	4.97e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SDC1—obesity	8.02e-07	4.91e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOE—obesity	8.02e-07	4.91e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CAV1—obesity	7.94e-07	4.86e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOA1—obesity	7.92e-07	4.85e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CD36—obesity	7.92e-07	4.85e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKR1C3—obesity	7.89e-07	4.83e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LPL—obesity	7.85e-07	4.81e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SCARB1—obesity	7.77e-07	4.76e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MTHFR—obesity	7.69e-07	4.71e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GPX1—obesity	7.66e-07	4.69e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.59e-07	4.65e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SREBF1—obesity	7.54e-07	4.62e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARA—obesity	7.54e-07	4.62e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MTHFR—obesity	7.5e-07	4.59e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CD36—obesity	7.46e-07	4.57e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARA—obesity	7.36e-07	4.51e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GOT2—obesity	7.34e-07	4.49e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AGT—obesity	7.3e-07	4.47e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CG—obesity	7.23e-07	4.43e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—FASN—obesity	7.18e-07	4.4e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOE—obesity	7.16e-07	4.38e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—BCHE—obesity	7.15e-07	4.38e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AGT—obesity	7.13e-07	4.36e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CAV1—obesity	7.09e-07	4.34e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOA1—obesity	7.07e-07	4.33e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MTHFR—obesity	7.07e-07	4.33e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOE—obesity	6.98e-07	4.28e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARG—obesity	6.98e-07	4.28e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARA—obesity	6.94e-07	4.25e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CAV1—obesity	6.92e-07	4.24e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOA1—obesity	6.9e-07	4.23e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2E1—obesity	6.9e-07	4.23e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—POMC—obesity	6.89e-07	4.22e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—INS—obesity	6.85e-07	4.19e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NQO1—obesity	6.82e-07	4.18e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	6.77e-07	4.15e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AGT—obesity	6.72e-07	4.11e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOE—obesity	6.58e-07	4.03e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GCG—obesity	6.54e-07	4.01e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC2A4—obesity	6.54e-07	4.01e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CAV1—obesity	6.52e-07	3.99e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOA1—obesity	6.51e-07	3.98e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CG—obesity	6.46e-07	3.95e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYCS—obesity	6.46e-07	3.95e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CD—obesity	6.36e-07	3.89e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GOT1—obesity	6.34e-07	3.88e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GGT1—obesity	6.34e-07	3.88e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CG—obesity	6.3e-07	3.86e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALB—obesity	6.28e-07	3.84e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NCOA1—obesity	6.24e-07	3.82e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARG—obesity	6.23e-07	3.82e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP19A1—obesity	6.15e-07	3.77e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—STK11—obesity	6.15e-07	3.77e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—POMC—obesity	6.15e-07	3.76e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—INS—obesity	6.11e-07	3.74e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARG—obesity	6.08e-07	3.72e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3R1—obesity	6.01e-07	3.68e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NOS3—obesity	6.01e-07	3.68e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—POMC—obesity	6e-07	3.67e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—INS—obesity	5.97e-07	3.65e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CG—obesity	5.94e-07	3.64e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARG—obesity	5.73e-07	3.51e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—COMT—obesity	5.72e-07	3.5e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CD—obesity	5.68e-07	3.48e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—POMC—obesity	5.65e-07	3.46e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GNB3—obesity	5.64e-07	3.45e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARGC1A—obesity	5.64e-07	3.45e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—INS—obesity	5.62e-07	3.44e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HMOX1—obesity	5.61e-07	3.44e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALB—obesity	5.6e-07	3.43e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CB—obesity	5.54e-07	3.39e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CD—obesity	5.54e-07	3.39e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS2—obesity	5.49e-07	3.36e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GNAS—obesity	5.49e-07	3.36e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALB—obesity	5.47e-07	3.35e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOB—obesity	5.38e-07	3.29e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3R1—obesity	5.36e-07	3.28e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NOS3—obesity	5.36e-07	3.28e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NOS3—obesity	5.23e-07	3.2e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3R1—obesity	5.23e-07	3.2e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CD—obesity	5.22e-07	3.2e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALB—obesity	5.15e-07	3.16e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LPL—obesity	5.13e-07	3.14e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GPX1—obesity	5.01e-07	3.07e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CB—obesity	4.95e-07	3.03e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3R1—obesity	4.93e-07	3.02e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NOS3—obesity	4.93e-07	3.02e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS2—obesity	4.9e-07	3e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CD36—obesity	4.88e-07	2.99e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CB—obesity	4.83e-07	2.96e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS2—obesity	4.79e-07	2.93e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MTHFR—obesity	4.62e-07	2.83e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CB—obesity	4.55e-07	2.79e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARA—obesity	4.53e-07	2.78e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS2—obesity	4.51e-07	2.76e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AGT—obesity	4.39e-07	2.69e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOE—obesity	4.3e-07	2.63e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CAV1—obesity	4.26e-07	2.61e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOA1—obesity	4.25e-07	2.6e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CG—obesity	3.88e-07	2.38e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARG—obesity	3.75e-07	2.29e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—POMC—obesity	3.7e-07	2.26e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—INS—obesity	3.68e-07	2.25e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CD—obesity	3.41e-07	2.09e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CA—obesity	3.38e-07	2.07e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALB—obesity	3.37e-07	2.06e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3R1—obesity	3.22e-07	1.97e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NOS3—obesity	3.22e-07	1.97e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CA—obesity	3.02e-07	1.85e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CB—obesity	2.98e-07	1.82e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS2—obesity	2.95e-07	1.81e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CA—obesity	2.94e-07	1.8e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CA—obesity	2.77e-07	1.7e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKT1—obesity	2.76e-07	1.69e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKT1—obesity	2.46e-07	1.51e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKT1—obesity	2.41e-07	1.47e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKT1—obesity	2.27e-07	1.39e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CA—obesity	1.81e-07	1.11e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKT1—obesity	1.48e-07	9.07e-06	CbGpPWpGaD
